魚類ワクチンの市場規模および予測（2020年～2030年）、世界および地域シェア、動向、成長機会分析レポートの対象範囲ワクチンタイプ別（不活化ワクチン、生ワクチン、サブユニットワクチン、組み換えベクターワクチン、その他）、用途別（細菌性、ウイルス性、寄生虫性）、投与経路別（注射、浸漬、経口）、魚種別（サケ、マス、ティラピア、その他）、地域別（北米、欧州、アジア太平洋、中東・アフリカ、中南米）

Fish Vaccine Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Vaccine Type (Inactivated Vaccines, Live Vaccines, Subunit Vaccines, Recombinant Vector Vaccine, and Others), Application (Bacterial, Viral, and Parasitic), Route of Administration (Injected, Immersion, and Oral), Species (Salmon, Trout, Tilapia, and Others), and Geography (North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America)

魚類ワクチンの市場規模は2022年に3.55億米ドルと評価され、2030年には6.17億米ドルに達すると予測されている。魚類ワクチン市場の成長は、主に水産養殖産業を発展させるための政府のイニシアチブの増加と水産動... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年9月28日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	180	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

魚類ワクチンの市場規模は2022年に3.55億米ドルと評価され、2030年には6.17億米ドルに達すると予測されている。魚類ワクチン市場の成長は、主に水産養殖産業を発展させるための政府のイニシアチブの増加と水産動物由来の食品に対する需要の急増によってもたらされる。

新規魚類ワクチンの開発が魚類ワクチン市場成長の機会

寄生虫、ウイルス、バクテリアによる病気の発生は、数十年にわたり世界の養殖産業の発展を遅らせてきた。人間の健康に有害であることはさておき、新興の疾病は水産動物に大きな影響を及ぼしている。従来のワクチンには限界や欠点があり、キメラマルチエピトープワクチンのような新規の先端ワクチンの開発需要が高まっている。水生ワクチンの基礎・応用研究分野では、科学技術の進歩により新たな道が開かれている。新たな技術、アプローチ、戦略を用いて、より高品質で効率的な新規水生ワクチンを創出する努力がなされている。

利用可能なバイオインフォマティクスツールやイムノプロテオミクスやゲノミクスの最新の知識を用いることで、研究者は免疫細胞が認識できる潜在的な標的エピトープを同定することができる。さらに、全ゲノム配列決定のような技術のコストが低下し続けるにつれて、種特異的ワクチン開発の道が開かれる。これにより、新規ワクチン開発への投資が活発化する可能性が高い。2021年、インドでは中央汽水養殖研究所（ICAR）がウイルス性神経壊死症（VNN）に対する組み換えワクチンを発売した。

このように、投与プロセスを強化した効果的な粘膜ワクチンの開発は、新規ワクチン開発を加速させ、地中海諸国の養殖事業を後押しし、魚類ワクチン接種プロセスを定期化させることが期待される。したがって、新規魚類ワクチンの開発は、市場成長のための大きな機会を生み出す可能性が高い。

ワクチンタイプ別インサイト

魚類ワクチン市場は、ワクチンタイプ別に不活化ワクチン、生ワクチン、サブユニットワクチン、組み換えベクターワクチン、その他に区分される。不活化ワクチンセグメントは2022年の魚類ワクチン市場で最大のシェアを占めた。しかし、組換えベクターワクチンセグメントは、2022-2030年の間に8.6%の最も高いCAGRを記録すると予測されている。

用途別洞察

魚類ワクチン市場は、用途別に細菌性、ウイルス性、寄生虫性に区分される。細菌セグメントは2022年に最大の市場シェアを占め、同セグメントは2022～2030年に7.4%の最高のCAGRを記録すると予測されている。

投与経路に基づく洞察

魚類ワクチン市場は、投与経路別に注射、浸漬、経口に区分される。2022年の魚類ワクチン市場シェアでは、注射セグメントが最大のシェアを占めている。しかし、浸漬セグメントは2022年から2030年の間に7.6%の高いCAGRを記録すると予測されている。

種ベースの洞察

魚種別ワクチン市場は、サケ、マス、ティラピア、その他に区分される。サケセグメントは2022年に最大の市場シェアを占めたが、その他セグメントは2022-2030年に7.8%の最高のCAGRを記録すると予測されている。

Cole Instruments Inc、Vision Medical Inc、Bernstein Medical PC、Curallux LLC、HairMax Inc、NovaGenix LLC、Apira Science Inc、Theradome Inc、Robotics Restoration Inc、LaserCap Coなどが世界の魚類ワクチン市場で活動する主要企業である。

レポートは世界の魚類ワクチン市場を以下のように区分している：

魚類ワクチン市場は、ワクチンタイプ、用途、投与経路、魚種に基づいて分割される。ワクチンタイプに基づき、魚類ワクチン市場は不活化ワクチン、生ワクチン、サブユニットワクチン、組み換えベクターワクチン、その他に区分されます。用途に基づき、魚類ワクチン市場は細菌性、ウイルス性、寄生虫性に区分される。投与経路に基づき、魚類ワクチン市場は注射、浸漬、経口に分類されます。魚種に基づき、魚類ワクチン市場はサケ、マス、ティラピア、その他に区分される。地域別では、魚類ワクチン市場は北米（米国、カナダ、メキシコ）、欧州（英国、ドイツ、フランス、イタリア、スペイン、欧州のその他）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、アジア太平洋のその他）、中東・アフリカ（UAE、サウジアラビア、南アフリカ、中東・アフリカのその他）、中南米（ブラジル、アルゼンチン、中南米のその他）に区分される。

魚類ワクチン市場に関するレポート作成時に参照した主な一次および二次情報源には、OECD/FAO、米国農務省（USDA）、世界銀行、米国海洋大気庁、カナダ漁業海洋省（DFO）、英国商務貿易省、オーストラリア国立漁業開発局（NFDB）、オーストラリア農漁業林業省などがあります。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Fish Vaccine Market, by Geography
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Fish Vaccine Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Fish Vaccine Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 Government Initiatives to Develop Aquaculture Industry
5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
5.2 Market Restraints
5.2.1 Stringent Regulations for Approval of Vaccine
5.3 Market Opportunities
5.3.1 Development of Novel Fish Vaccine
5.4 Future Trends
5.4.1 Technological Advancements in Fish Vaccine
5.5 Impact Analysis:
6. Fish Vaccine Market - Global Market Analysis
6.1 Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
7. Global Fish Vaccine Market – Revenue and Forecast to 2030 – by Vaccine Type
7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
7.3 Inactivated Vaccines
7.3.1 Overview
7.3.2 Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.4 Live Vaccines
7.4.1 Overview
7.4.2 Live Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.5 Subunit Vaccines
7.5.1 Overview
7.5.2 Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.6 Recombinant Vector Vaccine
7.6.1 Overview
7.6.2 Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.7 Others
7.7.1 Overview
7.7.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8. Global Fish Vaccine Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
8.3 Bacterial
8.3.1 Overview
8.3.2 Bacterial: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.4 Viral
8.4.1 Overview
8.4.2 Viral: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.5 Parasitic
8.5.1 Overview
8.5.2 Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9. Global Fish Vaccine Market – Revenue and Forecast to 2030 – by Route of Administration
9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
9.3 Injected
9.3.1 Overview
9.3.2 Injected: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.4 Immersion
9.4.1 Overview
9.4.2 Immersion: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.5 Oral
9.5.1 Overview
9.5.2 Oral: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10. Global Fish Vaccine Market – Revenue and Forecast to 2030 – by Species
10.1 Overview
10.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
10.3 Salmon
10.3.1 Overview
10.3.2 Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10.4 Trout
10.4.1 Overview
10.4.2 Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10.5 Tilapia
10.5.1 Overview
10.5.2 Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10.6 Others
10.6.1 Overview
10.6.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
11. Fish Vaccine Market - Geographical Analysis
11.1 North America Fish Vaccine Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.1.3 North America: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.1.4 North America: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.1.5 North America: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.1.6 North America: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.1.7 North America Fish Vaccine Market, by Country
11.1.7.1 US
11.1.7.1.1 Overview
11.1.7.1.2 US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.1.7.1.3 US: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.1.7.1.4 US: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.1.7.1.5 US: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.1.7.1.6 US: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.1.7.2 Canada
11.1.7.2.1 Overview
11.1.7.2.2 Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.1.7.2.3 Canada: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.1.7.2.4 Canada: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.1.7.2.5 Canada: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.1.7.2.6 Canada: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.1.7.3 Mexico
11.1.7.3.1 Overview
11.1.7.3.2 Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.1.7.3.3 Mexico: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.1.7.3.4 Mexico: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.1.7.3.5 Mexico: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.1.7.3.6 Mexico: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2 Europe Fish Vaccine Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.3 Europe: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.4 Europe: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.5 Europe: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.6 Europe: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7 Europe Fish Vaccine Market, by Country
11.2.7.1 UK
11.2.7.1.1 Overview
11.2.7.1.2 UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.1.3 UK: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.1.4 UK: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.1.5 UK: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.1.6 UK: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.2 Germany
11.2.7.2.1 Overview
11.2.7.2.2 Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.2.3 Germany: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.2.4 Germany: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.2.5 Germany: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.2.6 Germany: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.3 France
11.2.7.3.1 Overview
11.2.7.3.2 France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.3.3 France: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.3.4 France: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.3.5 France: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.3.6 France: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.4 Italy
11.2.7.4.1 Overview
11.2.7.4.2 Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.4.3 Italy: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.4.4 Italy: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.4.5 Italy: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.4.6 Italy: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.5 Spain
11.2.7.5.1 Overview
11.2.7.5.2 Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.5.3 Spain: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.5.4 Spain: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.5.5 Spain: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.5.6 Spain: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.6 Rest of Europe
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.6.3 Rest of Europe: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.6.4 Rest of Europe: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.6.5 Rest of Europe: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.6.6 Rest of Europe: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.3 Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.4 Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.5 Asia Pacific: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.6 Asia Pacific: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7 Asia Pacific Fish Vaccine Market, by Country
11.3.7.1 China
11.3.7.1.1 Overview
11.3.7.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.1.4 China: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.1.5 China: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.1.6 China: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.2 Japan
11.3.7.2.1 Overview
11.3.7.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.2.5 Japan: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.2.6 Japan: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.3 India
11.3.7.3.1 Overview
11.3.7.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.3.4 India: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.3.5 India: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.3.6 India: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.4 Australia
11.3.7.4.1 Overview
11.3.7.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.4.5 Australia: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.4.6 Australia: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.5 South Korea
11.3.7.5.1 Overview
11.3.7.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.5.5 South Korea: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.5.6 South Korea: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4 Middle East & Africa Fish Vaccine Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.3 Middle East & Africa: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.4 Middle East & Africa: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.5 Middle East & Africa: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6 Middle East & Africa: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4.6.1 Middle East & Africa Fish Vaccine Market, by Country
11.4.6.2 Saudi Arabia
11.4.6.2.1 Overview
11.4.6.2.2 Saudi Arabia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.6.2.3 Saudi Arabia: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.6.2.4 Saudi Arabia: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.6.2.5 Saudi Arabia: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6.2.6 Saudi Arabia: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4.6.3 South Africa
11.4.6.3.1 Overview
11.4.6.3.2 South Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.6.3.3 South Africa: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.6.3.4 South Africa: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.6.3.5 South Africa: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6.3.6 South Africa: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4.6.4 UAE
11.4.6.4.1 Overview
11.4.6.4.2 UAE Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.6.4.3 UAE: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.6.4.4 UAE: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.6.4.5 UAE: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6.4.6 UAE: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4.6.5 Rest of Middle East Africa
11.4.6.5.1 Overview
11.4.6.5.2 Rest of Middle East Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.6.5.3 Rest of Middle East Africa: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.6.5.4 Rest of Middle East Africa: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.6.5.5 Rest of Middle East Africa: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6.5.6 Rest of Middle East Africa: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.5 South & Central America Fish Vaccine Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.5.3 South & Central America: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.5.4 South & Central America: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.5.5 South & Central America: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.5.6 South & Central America: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.5.7 South & Central America Fish Vaccine Market, by Country
11.5.7.1 Brazil
11.5.7.1.1 Overview
11.5.7.1.2 Brazil Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.5.7.1.3 Brazil: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.5.7.1.4 Brazil: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.5.7.1.5 Brazil: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.5.7.1.6 Brazil: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.5.7.2 Argentina
11.5.7.2.1 Overview
11.5.7.2.2 Argentina Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.5.7.2.3 Argentina: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.5.7.2.4 Argentina: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.5.7.2.5 Argentina: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.5.7.2.6 Argentina: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.5.7.3 Rest of South & Central America
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.5.7.3.3 Rest of South & Central America: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.5.7.3.4 Rest of South & Central America: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.5.7.3.5 Rest of South & Central America: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.5.7.3.6 Rest of South & Central America: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
12. Fish Vaccine Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in Fish Vaccine Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Zoetis Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck & Co Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 HIPRA SA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Phibro Animal Health Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Vaxxinova International BV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Kyoto Biken Laboratories Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Elanco Animal Health Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Nisseiken Co Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 KBNP Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Choong Ang Vaccine Laboratory
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Indian Immunologicals Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The fish vaccine market size was valued at US$ 0.355 Bn in 2022 and is expected to reach US$ 0.617 Bn by 2030; it is estimated to record a CAGR of 7.1% from 2022 to 2030. The fish vaccine market growth is primarily driven by the increasing government initiatives to develop aquaculture industry and surging demand for aquatic animal-derived food products

Development of Novel Fish Vaccine Opportunity for Growth of Fish Vaccine Market

Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.

Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.

Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth

Vaccine Type-Based Insights

The fish vaccine market, by vaccine type, is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest share in fish vaccine market in 2022. However, recombinant vector vaccine segment is anticipated to register the highest CAGR of 8.6% during 2022-2030.

Application-Based Insights

The fish vaccine market, by application, is segmented into bacterial, viral, and parasitic. The bacterial segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR of 7.4% during 2022-2030.

Route of Administration -Based Insights

The fish vaccine market, by route of administration, is segmented into injected, immersion, and oral. The injected segment held the largest share in fish vaccine market share in 2022. However, immersion segment is anticipated to register a highest CAGR of 7.6% during 2022-2030.

Species-Based Insights

The fish vaccine market, by species, is segment into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022 whereas, others segment is anticipated to register the highest CAGR of 7.8% during 2022-2030

Cole Instruments Inc, Vision Medical Inc, Bernstein Medical PC, Curallux LLC, HairMax Inc, NovaGenix LLC, Apira Science Inc, Theradome Inc, Robotics Restoration Inc, and LaserCap Co are among the key players operating in the global fish vaccine market.

The report segments the global fish vaccine market as follows:

The fish vaccine market is divided on the basis of vaccine type, application, route of administration, and species. Based on vaccine type, the fish vaccine market is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. Based on the application, the fish vaccine market is segmented into bacterial, viral, and parasitic. Based on the route of administration, the fish vaccine market is classified into injected, immersion, and oral. Based on species, the fish vaccine market is segmented into salmon, trout, tilapia, and others. Based on geography, the fish vaccine market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

A few of the major primary and secondary sources referred to while preparing the report on the fish vaccine market are the OECD/FAO, US Department of Agriculture (USDA), World Bank, the National Oceanic and Atmospheric Administration, Fisheries and Oceans Canada (DFO), Department of Business and Trade (UK), National Fisheries Development Board (NFDB), Department of Agriculture, Fisheries and Forestry of Australia

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（fish）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（fish）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?